###begin article-title 0
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
Haploinsufficiency of Activation-Induced Deaminase for Antibody Diversification and Chromosome Translocations both In Vitro and In Vivo
###end article-title 0
###begin p 1
Conceived and designed the experiments: IVS VGdY ARR. Performed the experiments: IVS VGdY YD. Analyzed the data: IVS VGdY ARR. Contributed reagents/materials/analysis tools: ARR. Wrote the paper: VGdY ARR.
###end p 1
###begin p 2
###xml 630 637 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 747 750 747 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 756 759 756 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 912 915 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1096 1099 1096 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1247 1250 1247 1250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1262 1269 1262 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1274 1282 1274 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 877 883 <span type="species:ncbi:9606">humans</span>
###xml 1100 1104 <span type="species:ncbi:10090">mice</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
The humoral immune response critically relies on the secondary diversification of antibodies. This diversification takes places through somatic remodelling of the antibody genes by two molecular mechanisms, Class Switch Recombination (CSR) and Somatic Hypermutation (SHM). The enzyme Activation Induced Cytidine Deaminase (AID) initiates both SHM and CSR by deaminating cytosine residues on the DNA of immunoglobulin genes. While crucial for immunity, AID-catalysed deamination is also the triggering event for the generation of lymphomagenic chromosome translocations. To address whether restricting the levels of AID expression in vivo contributes to the regulation of its function, we analysed mice harbouring a single copy of the AID gene (AID+/-). AID+/- mice express roughly 50% of normal AID levels, and display a mild hyperplasia, reminiscent of AID deficient mice and humans. Moreover, we found that AID+/- cells have an impaired competence for CSR and SHM, which indicates that AID gene dose is limiting for its physiologic function. We next evaluated the impact of AID reduction in AID+/- mice on the generation of chromosome translocations. Our results show that the frequency of AID-promoted c-myc/IgH translocations is reduced in AID+/- mice, both in vivo and in vitro. Therefore, AID is haploinsufficient for antibody diversification and chromosome translocations. These findings suggest that limiting the physiologic levels of AID expression can be a regulatory mechanism that ensures an optimal balance between immune proficiency and genome integrity.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Schatz1">[1]</xref>
###xml 1077 1080 1077 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Peled1">[2]</xref>
###xml 1085 1088 1085 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-DiNoia1">[3]</xref>
###xml 1661 1664 1630 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Stavnezer1">[4]</xref>
###xml 1666 1669 1635 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Stavnezer2">[5]</xref>
B cells are responsible for generating a repertoire of antibodies of virtually unlimited diversity in order to confront the antigenic universe. Antibody diversification is achieved through somatic remodelling of immunoglobulin (Ig) genes at two different stages of B cell differentiation. The first one is antigen- independent and takes place during B cell generation in the bone marrow through a site-specific recombination named V(D)J recombination, which gives rise to B cells expressing a primary repertoire of Iow affinity IgM antibodies (reviewed in [1]). Upon antigen encounter B cells have as yet another chance to further diversify their antibody repertoire in germinal centers by two independent molecular mechanisms called somatic hypermutation (SHM) and class switch recombination (CSR). SHM reshapes the antigen binding site of Igs by introducing nucleotide changes in their variable genes. B cells where SHM gives rise to antibodies with higher affinity for their cognate antigen are positively selected, a process referred to as affinity maturation (reviewed in [2] and [3]). CSR is a region-specific recombination reaction that replaces the primary mu constant (Cmu) region by a downstream constant region (Cgamma, Cepsilon or Calpha), thereby generating antibodies endowed with new functions for pathogen neutralization while retaining the same antigen specificity. CSR takes place between highly repetitive sequences that precede the Cmu, Cgamma, Cepsilon and Calpha genes, called switch regions, through the generation of double strand breaks (DSBs), ligation, and concomitant excision of the intervening sequence from the locus (reviewed in [4], [5]).
###end p 4
###begin p 5
###xml 100 103 100 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Muramatsu1">[6]</xref>
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Revy1">[7]</xref>
###xml 366 369 366 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Revy1">[7]</xref>
###xml 495 498 495 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Bransteitter1">[8]</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Chaudhuri1">[9]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dickerson1">[10]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-PetersenMahrt1">[11]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pham1">[12]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro1">[13]</xref>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-PetersenMahrt1">[11]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-DiNoia2">[14]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Rada1">[15]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Rada2">[16]</xref>
###xml 108 114 <span type="species:ncbi:9606">humans</span>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
Both SHM and CSR are initiated by the very same enzyme, Activation Induced Cytidine Deaminase (AID) [6]. In humans, mutations in the AID gene are associated with a rare (1/2000000) immunodeficiency called Hyper IgM Syndrome type 2 (HIGM2) [7]. HIGM2 patients display impaired CSR and SHM and are prone to bacterial infections of the respiratory and digestive tracts [7]. AID initiates SHM and CSR by deaminating cytosine residues of the variable and switch regions of the Ig genes, respectively [8], [9], [10], [11], [12], [13]. Cytosine deamination on DNA converts a normal C:G pair into a U:G mismatch. AID-generated U:G mismatches are processed through uracil removal by Uracil-N-Glycosylase (UNG) or through recognition by the mismatch repair (MMR) machinery, which results in the generation of either a mutation (SHM) or a DSB (CSR) [11], [14], [15], [16].
###end p 5
###begin p 6
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kuppers1">[17]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kuppers2">[18]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kuppers1">[17]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kuppers2">[18]</xref>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 325 333 325 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro2">[20]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pasqualucci1">[22]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro2">[20]</xref>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kovalchuk1">[23]</xref>
###xml 791 795 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pasqualucci1">[22]</xref>
###xml 830 834 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kotani1">[24]</xref>
###xml 876 880 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Chesi1">[25]</xref>
###xml 797 800 <span type="species:ncbi:8790">Emu</span>
Most of the lymphomas diagnosed in the western world arise from mature B cells and are characterized by the presence of chromosomal translocations that involve one of the Ig loci and a proto-oncogene [17], [18]. These translocations are known to play a role in the etiology of these B cell neoplasias [17], [18]. In vivo and in vitro studies have shown that AID can promote the generation of pro-lymphomagenic translocations [19], [20], [21], [22], and that CSR and the translocation reaction are initiated by a common pathway that involves DNA deamination and UNG [20]. The impact of AID function in B cell neoplasia development has been addressed in a number of in vivo models, including IL6 [19], [21] and pristane [23] promoted plasmacytomas, BCL-6-induced diffuse large B cell lymphoma [22], Emu-Myc model of B cell lymphoma [24] and a myc-induced multiple myeloma model [25]. In all the cases absence of AID either delayed the onset or shifted the nature of the neoplasia towards a more immature origin, hence reinforcing the idea that AID expression plays a role in the generation of mature B cell lymphomas by promoting DNA lesions.
###end p 6
###begin p 7
Therefore, AID function, while crucial to the development of an efficient immune response, can pose a risk to DNA stability in B cells. Different regulatory mechanisms may be responsible to minimize unwanted DNA damage by AID.
###end p 7
###begin p 8
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Odegard1">[26]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pasqualucci2">[27]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Liu1">[28]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ito1">[29]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-McBride1">[30]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Muramatsu2">[31]</xref>
###xml 537 540 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-deYebenes1">[32]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett2">[33]</xref>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Teng1">[34]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-deYebenes2">[35]</xref>
First, AID mutagenic activity is mostly limited to the Ig loci (reviewed in [26]), and although AID-induced lesions in other genes have been reported [27], [28], these events are rare. Second, AID accessibility to DNA is restrained by fine control of subcellular localization [29], [30]. Third, the presence of AID mRNA is mainly restricted to activated mature B cells [31], thus limiting its function to the cell type and time window where it is required. Transcriptional regulation exerted by B cell specific transcription factors and cis elements (reviewed in [32], as well as microRNA-mediated post-transcriptional regulation [33], [34], [35] contribute to this expression pattern.
###end p 8
###begin p 9
###xml 213 216 213 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
We hypothesized that limiting physiological AID expression levels could provide an additional mechanism to restrict its deleterious activity. To address this question we analysed the impact of AID reduction in AID+/- mice on CSR, SHM and the generation of chromosome translocations.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
AID expression is limiting for its function in CSR
###end title 11
###begin p 12
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 517 520 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 528 531 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 549 557 549 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 781 784 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 813 816 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 826 835 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1a</xref>
###xml 921 924 921 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Muramatsu1">[6]</xref>
###xml 943 946 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1023 1026 1023 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1028 1037 1028 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1b</xref>
###xml 1158 1159 1158 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1162 1163 1162 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1184 1193 1184 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1c</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
In order to assess whether physiologic AID expression level is limiting for its function, we evaluated AID gene dose effect in mice harbouring one or two functional alleles of the AID gene, AID+/- and AID+/+ mice, respectively. B cells from congenic Balb/c ByJ animals [21] were used to minimize strain-to-strain variations. We first wanted to ascertain that deletion of one AID allele in AID+/- mice resulted in a reduction of AID levels as compared to AID+/+ mice. Mature B cells were isolated from spleens from AID+/+ and AID+/- mice, stimulated in vitro in the presence of LPS and IL4 to promote AID transcriptional activation, and AID expression was quantified after 3 days of culture by real-time RT-PCR. We found that indeed AID mRNA levels are reduced roughly to 50% in AID+/- as compared to wild type AID+/+ B cells (Figure 1a). AID deficient mice display a mild B cell hyperplasia and enlarged germinal centers [6]. We found that AID+/- mice have slightly increased numbers of B cells in spleen as compared to AID+/+ (Figure 1b) and contain a higher proportion of germinal center B cells in Peyer's patches, as measured by the expression of the GL7+Fas+ activation markers (Figure 1c).
###end p 12
###begin title 13
AID is haploinsufficient for CSR.
###end title 13
###begin p 14
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 268 271 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 532 535 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 569 572 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 592 595 592 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 595 597 595 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 601 603 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/</sup>
###xml 611 613 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 649 652 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 682 683 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 725 728 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 733 736 733 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 744 747 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 848 849 848 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 852 853 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 973 976 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 989 992 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1008 1011 1008 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1174 1177 1174 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1210 1213 1210 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1218 1221 1218 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1229 1232 1229 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1424 1425 1424 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1495 1498 1495 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1503 1506 1503 1506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1514 1517 1514 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1617 1618 1617 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1730 1733 1730 1733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1740 1743 1740 1743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1786 1788 1786 1788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1800 1802 1800 1802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1833 1835 1833 1835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1969 1972 1969 1972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 2075 2079 2075 2079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E58Q</sup>
###xml 2276 2277 2276 2277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2298 2299 2298 2299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2344 2345 2344 2345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2369 2373 2369 2373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E58Q</sup>
###xml 2377 2378 2377 2378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1973 1977 <span type="species:ncbi:10090">mice</span>
(A) AID levels are reduced in AID+/- mice. Spleen B cells from AID+/+, AID+/- and AID-/- were stimulated for 3 days in the presence of LPS and IL4. RNA was isolated and AID expression was assessed by real-time RT-PCR. Bars represent AID mRNA expression relative to AID+/+ B cells. Statistical error bars show standard deviation (n = 5). ND, non-detectable. (B) AID+/- spleens contain increased numbers of B cells. Bars represent the number of spleen B cells (CD43 negative) and statistical bars represent standard deviations. n (AID+/+) = 18, n (AID+/-) = 16 and n (AID-/-) = 9. t test p (AID+/+vs AID+/) = 6x10-4. (C) Peyer's patch B cells from AID+/- mice contain intermediate Fas+GL7+ cell numbers. Spleen B cells from AID+/+, AID+/- and AID-/- were stained with anti-Fas and anti-GL7 antibodies and analysed by flow cytometry. Percentage of Fas+GL7+ cells is indicated. One representative experiment is shown (n = 3). (D) ELISA quantification of IgG serum levels in AID+/+ (n = 5), AID+/- (n = 5) and AID-/- (n = 3) mice 15 days after NP-CGG (black bars) or PBS (white bars) injection. Statistical bars represent standard deviations. (E) CSR efficiency is reduced in AID+/- B cells. Spleen B cells from AID+/+, AID+/- and AID-/- were stimulated for 3 days in the presence of LPS and IL4. CSR to IgG1 was measured by flow cytometry. Representative plots of CFSE labelling and IgG1 expression are shown. Percentage of IgG1+ cells is indicated. (F) Time-course analysis of CSR. B cells from AID+/+, AID+/- and AID-/- were stimulated for the indicated times (X axis) in the presence of LPS and IL4. Percentage of IgG1+ as measured by flow cytometry is represented (Y axis). Statistical bars show standard deviations. p values (AID+/- vs AID+/+) for IgG1: 48h, 0.04; 72h, 0.03; 96h, 6x10-3; 120h, 3x10-3; for IgG3: 48h, 0.1; 72h, 8x10-3; 96h, 0.02; 120h, 0.02 (unpaired two-tailed Student's t test, n = 9). (G-H) AID overexpression increases CSR. Spleen B cells from AID+/+ mice were transduced with retroviral vectors encoding wild type (AID) or a catalitically inactive (AIDE58Q) AID along with GFP to monitor transduction. CSR to IgG1 was measured by flow cytometry 2 days after transduction. (G) A representative flow cytometry plot is shown in panel G. Percentages of IgG1+ cells within the GFP+ population are shown. (H) Percentage of IgG1+ cells within AID or AIDE58Q GFP+ cells determined in 4 independent experiments. Statistical bars represent standard deviations. Statistically significant differences (p< = 0.05) are indicated with a (*) (A-H).
###end p 14
###begin p 15
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
The above results indicate that AID+/- cells express reduced levels of AID mRNA and show hyperactivation features that are intermediate between AID proficient (AID+/+) and AID deficient (AID-/-) cells.
###end p 15
###begin p 16
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Muramatsu1">[6]</xref>
###xml 353 362 353 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1d</xref>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Takizawa1">[36]</xref>
###xml 695 698 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 703 706 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 714 717 714 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 854 857 854 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 917 926 917 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1e</xref>
###xml 987 996 987 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1a</xref>
###xml 1019 1022 1019 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1038 1041 1038 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1106 1115 1106 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1f</xref>
###xml 1291 1300 1291 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1e</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
To address if reduced AID expression in AID+/- B cells results in a decrease of serum Ig levels, we immunized AID+/+, AID+/- and AID-/- mice with NP-CGG and analysed Ig concentration by ELISA. In agreement with previously reported data [6], we found no significant difference in serum Ig concentration between heterozygous and fully deficient AID mice (Figure 1d), presumably due to the high variablity in Ig titers. This result is consistent with the finding by Takizawa et al that decreased Ig titers in immunized AID+/- mice is only detected for antigen-specific high affinity antibodies [36]. To directly measure the impact of AID reduction on the induction of CSR, B cells isolated from AID+/+, AID+/- and AID-/- spleens were stimulated in the presence of LPS and IL4 to promote CSR to IgG1. FACS analysis after 2 days of stimulation showed that AID+/- B cells show a reduction in the efficiency of CSR to IgG1 (Figure 1e) which parallels the observed reduction of AID mRNA levels (Figure 1a). CSR reduction in AID+/- compared to AID+/+ B cells can be observed throughout the duration of the culture (Figure 1f) both for IgG1 isotype (LPS+IL4 stimulation, graph on the left) and for IgG3 isotype (LPS stimulation, graph on the right), and was not associated with proliferation defects (Figure 1e and not shown).
###end p 16
###begin p 17
###xml 224 228 224 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E58Q</sup>
###xml 331 335 331 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E58Q</sup>
###xml 487 502 487 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g001">Figure 1g and h</xref>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
We next asked if surpassing the level of physiologic AID expression would conversely result in an increase of CSR. To approach this issue we transduced spleen B cells from wild type mice with retroviruses encoding AID or AIDE58Q catalytically inactive mutant, together with GFP for tracking purposes. We found that AID, but not AIDE58Q overexpression, promotes an increase in the efficiency of CSR, as measured by the expression of IgG1 after stimulation in the presence of LPS and IL4 (Figure 1g and h).
###end p 17
###begin p 18
From these results we conclude that AID gene dose affects the efficiency of CSR in primary B cells, which implies that the AID gene is haploinsufficient for CSR.
###end p 18
###begin title 19
AID expression is limiting for SHM
###end title 19
###begin p 20
###xml 296 299 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 307 310 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 582 585 578 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 606 609 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 623 625 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 625 627 621 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 634 636 630 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 698 699 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 717 726 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g002">Figure 2a</xref>
###xml 764 771 760 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 788 789 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 792 793 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 824 827 820 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 835 838 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 974 977 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1015 1018 1011 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1032 1034 1028 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1034 1036 1030 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1043 1045 1039 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1045 1046 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1064 1073 1060 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g002">Figure 2b</xref>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
To assess whether AID haploinsufficiency was also evident on its activity in SHM we first analysed the accumulation of mutations in the 5' end of the mu switch region (Smu). AID activity during CSR leads to the introduction of mutations in Smu. We stimulated CFSE-labelled spleen B cells from AID+/+ and AID+/- mice in the presence of LPS and IL4 for 96h and quantified the accumulation of mutations in cells that had undergone 5 or more divisions after sorting, DNA extraction, PCR amplification, cloning and sequencing. We found a lower mutation frequency in the Smu region of AID+/- when compared to AID+/+ cells (1.2x10-4vs 1.9x10-4) although this difference was not statistically significant (t test p = 0.171) (Figure 2a). We next examined the SHM frequency in vivo by isolating Fas+GL7+ germinal centre cells from AID+/- and AID+/+ peyer's patches and sequencing of the intronic region immediately downstream of the JH4 gene. Our analysis showed that B cells from AID+/- mice contain fewer mutations than AID+/+ cells (0.9x10-3vs 3.1x10-3t test p = 0.011) (Figure 2b). From these results we conclude that AID is also haploinsufficient for SHM and therefore that the physiologic level of AID expression is limiting for the diversification of antibodies.
###end p 20
###begin title 21
AID is haploinsufficient for SHM.
###end title 21
###begin p 22
###xml 33 36 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 44 47 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 612 613 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 655 658 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 666 669 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 788 791 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 799 802 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 930 931 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 934 935 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 991 994 988 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1002 1005 999 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1244 1245 1241 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1300 1303 1297 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1311 1314 1308 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
(A) Smu mutation frequency in AID+/+ and AID+/- activated B cells. The Smu mutation frequency was quantified in sorted CFSE-labelled spleen B cells that had undergone 5 or more divisions after 96h of LPS and IL4 stimulation. Segment sizes in the pie charts are proportional to the number of Smu sequences carrying the number of mutations indicated in the periphery of the charts. The total number of independent sequences analyzed is indicated in the center of each chart. The calculated mutation frequency per base pair is indicated underneath. Statistical significance was determined by a two-tailed Student's t test comparing the frequency found in AID+/+ and AID+/- B cells. P values are indicated. (B) SHM analyzed in the intronic region 3' of JH4 of germinal center B cells from AID+/+ and AID+/- mice. Segment sizes in the pie charts are proportional to the number of mutations found in the intronic region 3' of JH4 of Fas+GL7+ sorted B cells from Peyer's patches of aged-matched AID+/+ and AID+/- mice. The total number of independent sequences analyzed is indicated in the center of each chart. The calculated mutation frequency per base pair is indicated underneath. Statistical significance was determined by a two-tailed Student's t test comparing the frequency of mutations found in AID+/+ and AID+/- mice. P values are indicated.
###end p 22
###begin title 23
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
B cells from IL6tgAID+/- hyperplastic lymph nodes harbour fewer translocations than IL6tgAID+/+ B cells
###end title 23
###begin p 24
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 800 801 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 902 906 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 908 912 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 914 918 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kovalchuk2">[37]</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
IL6 transgenic (IL6tg) mice develop lymphoid hyperplasia, presumably resulting from IL6-induced proliferation protection of mature B cells from apoptosis. Hyperplastic lymphoid tissues from IL6tg mice are enriched in B cells that harbour chromosomal translocations involving the IgH locus and the c-myc proto-oncogene (c-myc/IgH), analogous to those found in human Burkitt lymphoma. In the absence of AID, IL6tg B cells are devoid of c-myc/IgH translocations and the onset of lymphoid hyperplasia is delayed [19], [21]. Breakpoints of c-myc/IgH translocations found in IL6tg mice cluster in a narrow region of the c-myc gene, which encompasses part of its first exon and first intron. In contrast, translocation breakpoints have been found spreading over a large region of the IgH locus, from the V-JH region to the alpha switch (Salpha), which precedes the most distal alpha constant (Calpha) segment [19], [21], [37]. This distribution likely reflects the sites of AID-initiated double strand breaks during CSR and on occasion, during SHM.
###end p 24
###begin p 25
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 457 461 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kovalchuk3">[38]</xref>
###xml 463 472 453 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3a</xref>
###xml 560 563 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 572 574 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 609 612 599 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 621 623 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 626 635 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3c</xref>
To determine if AID gene dose has an influence on the frequency or distribution of c-myc/IgH translocations in vivo we analysed B cells from IL6tgAID+/+ and IL6tgAID+/- hyperplastic lymph nodes by long-range PCR, cloning and sequencing. Oligonucleotides priming at the mu switch (Smu) region or at the Salpha region of the IgH were combined with c-myc oligonucleotides to detect proximal, c-myc/IgHmu or distal, c-myc/IgHalpha, translocations, respectively [38] (Figure 3a). We found that the total frequency of c-myc/IgH translocations was reduced in IL6tgAID+/- (0,77x10-4) B cells when compared to IL6tgAID+/+ (1,95x10-4) (Figure 3c, left).
###end p 25
###begin title 26
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
c-myc/IgH translocation frequency is reduced in IL6tgAID+/- mice.
###end title 26
###begin p 27
###xml 209 210 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 591 594 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 620 623 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 660 663 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 676 679 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 742 763 726 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
###xml 992 995 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1008 1011 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1418 1421 1396 1399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1434 1437 1412 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1648 1651 1626 1629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1671 1674 1649 1652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 337 340 <span type="species:ncbi:8790">Emu</span>
###xml 381 389 <span type="species:ncbi:301928">ellipses</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 890 895 <span type="species:ncbi:10090">Mouse</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1706 1709 <span type="species:ncbi:8790">Emu</span>
(A) Schematic representation of the IgH and c-myc genes (upper) and the derivative chromosomes (c-myc/IgHmu and c-myc/IgHalpha, lower) arising from proximal and distal translocations, respectively. Variable (VH) and constant (Cmu and Calpha) genes are represented as grey and black boxes, respectively. Smu and Salpha switch regions and Emu enhancer are shown as striped and black ellipses, respectively. C-myc exons are drawn as white boxes. Arrows show the position of primers used for PCR amplification. (B) Proximal (left) and distal (right) c-myc/IgH translocations detected in IL6tgAID+/+ (upper gels) and IL6tgAID+/- (lower gels) mice. DNA from IL6tgAID+/+ and IL6tgAID+/- hyperplastic lymph node B cells was amplified as described in materials and methods using the primers depicted in (A). Representative amplification products analysed in ethidium bromide stained gels are shown. Mouse identifications are shown above the lanes. (C) Frequency of c-myc/IgH translocations in IL6tgAID+/+ and IL6tgAID+/- mice. Translocation frequency was determined by serial dilution of DNA samples, followed by PCR amplification, cloning and sequencing. Graphs show the overall translocation frequency (left), frequency of proximal c-myc/IgHmu translocations (middle) and frequency of distal c-myc/IgHalpha translocations (right). (D) Representation of translocation breakpoints at the c-myc and IgHmu genes found in IL6tgAID+/+ and IL6tgAID+/- B cells. Amplification products of proximal c-myc/IgH translocations were cloned and sequenced. Translocation breakpoints at the c-myc (upper diagram) and IgH (lower diagram) genes are shown as closed (IL6tgAID+/+) and open (IL6tgAID+/-) circles. C-myc exon 1 and IgH Emu enhancer are represented as grey boxes and distance to these elements is shown underneath (bps). Arrows on the right indicate the position of the PCR oligonucleotides used for amplification.
###end p 27
###begin p 28
###xml 72 75 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 88 91 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 136 140 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 142 146 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kovalchuk2">[37]</xref>
###xml 148 157 147 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3b</xref>
###xml 352 355 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 383 386 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 394 403 392 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3c</xref>
###xml 419 421 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 421 423 419 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 430 432 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 460 463 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 476 479 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 552 561 550 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3d</xref>
###xml 566 573 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003927-t001">Table 1</xref>
###xml 762 771 760 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3d</xref>
###xml 861 864 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 874 883 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3d</xref>
###xml 1078 1081 1075 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1094 1097 1091 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 834 837 <span type="species:ncbi:8790">Emu</span>
We readily detected proximal c-myc/IgHmu translocations in both IL6tgAID+/+ and IL6tgAID+/- B cells, in agreement with previous reports [21], [37] (Figure 3b). When the frequency of c-myc/IgHmu translocations was calculated by performing serial dilutions of B cell samples from hyperplasic lymph nodes, we found that it was slightly reduced in IL6tgAID+/- when compared with IL6tgAID+/+ cells (Figure 3c, middle; 1.2x10-4vs 0.8x10-4). Breakpoints from IL6tgAID+/+ and IL6tgAID+/- translocations were mapped and characterized by cloning and sequencing (Figure 3d and Table 1). We found that translocation breakpoints at the c-myc gene mostly clustered at the end of the first exon and the beginning of the first intron, regardless of the genotype being analysed (Figure 3d). Breakpoints at the IgH locus were slightly more proximal to Emu in the case of IL6tgAID+/+ B cells (Figure 3d), although this difference was not statistically significant. Both mutation frequency nearby translocation junctions and number of microhomology nucleotides at junctions were similar in IL6tgAID+/+ and IL6tgAID+/- B cells.
###end p 28
###begin title 29
###xml 46 50 <span type="species:ncbi:10090">mice</span>
c-myc/IgH chromosomal translocations in IL6tg mice
###end title 29
###begin p 30
Proximal (IgHmu) or distal (IgHalpha) c-myc/IgH chromosomal translocation.
###end p 30
###begin p 31
###xml 39 48 39 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g002">figure 2b</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse identification as referred to in figure 2b.
###end p 31
###begin p 32
c-myc sequence adjacent to translocation junction. Mutations are shown in lowercase.
###end p 32
###begin p 33
Microhomology at junctions (overlapping sequences that cannot be assigned to a single sequence, c-myc, or Ig).
###end p 33
###begin p 34
IgH Reverse complementary sequence adjacent to translocation junction. Mutations are shown in lowercase.
###end p 34
###begin p 35
###xml 140 143 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 193 196 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 212 223 207 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3b&#8211;c</xref>
###xml 250 257 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 302 305 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
In contrast to c-myc/IgHmu proximal translocations, we found that distal c-myc/IgHalpha translocations, while present in 20% of the IL6tgAID+/+ samples, were not detected in any of the IL6tgAID+/- mice analysed (Figure 3b-c, right). We conclude that in vivo, the reduction of AID expression in IL6tgAID+/- mice results in a shifted pattern and reduced frequency of c-myc-IgH translocations.
###end p 35
###begin title 36
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
The frequency of c-myc/IgH translocations generated in vitro is reduced in AID+/- B cells
###end title 36
###begin p 37
###xml 387 395 387 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 605 613 605 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 841 844 841 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1195 1198 1195 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1395 1398 1395 1398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Lymphoid hyperplasia generated in IL6tg mice is a long latency disease presumably involving complex selective events which can bias the number and nature of the translocations found in sick animals. In order to assess more faithfully the effect of limiting AID gene dose on the generation of chromosomal translocations, we analysed the frequency of these events as generated after short in vitro cultures of primary B cells. C-myc/IgH translocations are initiated in B cells through the same molecular pathway as CSR, which involves cytosine deamination by AID, and UNG. This process can be recapitulated in vitro by stimulating spleen B cells in the presence of LPS and IL4. The frequency of these events in wild type B cells is extremely low (below one translocation every ten million cells), but it is increased in the absence of p53, p19ARF or ATM, reflecting that DNA damage and oncogenic stress pathways are activated downstream of AID function to prevent aberrant joinings or spreading of cells that harbour lymphomagenic translocations. In particular, p53-mediated protection against AID-triggered c-myc/IgH translocations seems to require both alleles of the tumor suppressor, since p53+/- B cells display a dramatic increase in translocation frequency when compared to wild type littermates. Therefore we decided to exploit the higher frequency of c-myc/IgH translocations found in p53+/- B cells to determine whether restricting AID expression levels has an impact on the occurrence of these events.
###end p 37
###begin p 38
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 282 285 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 433 442 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g004">Figure 4a</xref>
###xml 504 507 504 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
To verify that the p53+/- genotype or the mixed strain of these mice do not interfere with AID haploinsufficiency (described above), we generated p53+/-AID+/+ and p53+/-AID+/- animals and analysed the efficiency of CSR in LPS+IL4 B cell cultures. Expectedly, we found that p53+/-AID+/- B cells show a decreased level of CSR when compared to p53+/-AID+/+ cells, as measured by the expression of IgG1 at different culture time-points (Figure 4a). This reduction is comparable to that observed in Balb/c p53+/+ mice (see above).
###end p 38
###begin title 39
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
c-myc/IgH translocation frequency is reduced in activated AID+/- B cells.
###end title 39
###begin p 40
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 203 204 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 316 319 316 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 325 327 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 337 340 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 409 410 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 484 487 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 490 493 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 501 504 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 507 510 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 566 569 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 726 732 726 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g002">Fig 2a</xref>
###xml 738 759 738 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
###xml 969 972 969 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 975 978 975 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 986 989 986 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 992 995 992 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1159 1162 1159 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1165 1168 1165 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1176 1179 1176 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1182 1185 1182 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1413 1416 1412 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1419 1422 1418 1421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1430 1433 1429 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1436 1439 1435 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1636 1639 1635 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1642 1645 1641 1644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1660 1663 1659 1662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1666 1669 1665 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 1701 1704 <span type="species:ncbi:8790">Emu</span>
(A) p53+/-AID+/- cells are haploinsufficient for CSR. Spleen B cells from p53+/-AID+/+ and p53+/-AID+/- were stimulated for the indicated times (X axis) in the presence of LPS and IL4. Percentage of IgG1+ as measured by flow cytometry is represented (Y axis). Statistical bars show standard deviations. p values (p53+/-AID+/-vs p53+/-AID+/+) 48h, 0.7; 72h, 0.01; 96h, 6x10-3; 120h, 0.03. (unpaired two-tailed t test, n = 4). (B) Representative c-myc/IgH translocations detected in p53+/-AID+/+ and p53+/-AID+/- B cells. Spleen B cells from p53+/-AID+/+ and p53+/-AID+/- mice were stimulated in vitro in the presence of LPS and IL4 for 3 days. DNA was extracted and proximal translocations were amplified by PCR as depicted in Fig 2a (see materials and methods) and analysed in ethidium bromide stained agarose gels (upper). Specificity of amplification products was determined by southern blot and hybridization with IgH (middle) and myc (lower) probes. Results for p53+/-AID+/+ and p53+/-AID+/- cells are shown on the left and right gels, respectively. Translocation identifications are indicated above lanes. (C) Frequency of c-myc/IgH translocations in p53+/-AID+/+ and p53+/-AID+/- B cells. Translocation frequency was determined by serial dilution of DNA samples, followed by PCR amplification, cloning and sequencing. (D) Representation of translocation breakpoints at the c-myc and IgHmu genes found in p53+/-AID+/+ and p53+/-AID+/- B cells. Amplification products of c-myc/IgH translocations were cloned and sequenced. Translocation breakpoints at the c-myc (upper diagram) and IgH (lower diagram) genes are shown as closed (p53+/-AID+/+) and open (p53+/-AID+/-) circles. C-myc exon 1 and IgH Emu enhancer are represented as grey boxes and distance to these elements is shown underneath (bps). Arrows on the right indicate the position of the PCR oligonucleotides used for amplification.
###end p 40
###begin p 41
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 260 269 260 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g003">Figure 3a</xref>
###xml 467 476 467 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g004">Figure 4b</xref>
###xml 615 618 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 651 654 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 657 660 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 669 671 669 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 671 673 671 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 681 683 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 685 691 685 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fisher</italic>
###xml 797 806 797 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g004">Figure 4d</xref>
###xml 850 857 850 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003927-t002">Table 2</xref>
###xml 865 868 865 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 871 874 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 874 876 874 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 880 883 880 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 887 890 887 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
Translocation frequency was then assessed in p53+/-AID+/+ and p53+/-AID+/- spleen B cells upon LPS+IL4 activation. Spleen B cells were isolated from 10 independent mice (5 mice per genotype), and the presence of translocations was analysed by PCR (depicted in Figure 3a, left) in 90 million cells (45 million cells per genotype) after 3 days of stimulation. Translocation identity was verified after gel analysis, southern blot with IgH- and myc-specific probes (see Figure 4b for representative gels), cloning, and sequencing. We found that the frequency of c-myc/IgH translocations is significantly reduced in p53+/-AID+/- B cells as compared to p53+/-AID+/+ (0,19x10-6vs 0,61x10-6, Fisher test p = 0,0025). We did not find significant differences regarding translocation breakpoints (mapped in Figure 4d), mutations or microhomology at junctions (Table 2) in p53+/-AID+/-vs p53+/- AID+/+ translocations.
###end p 41
###begin title 42
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
c-myc/IgH chromosomal translocations generated in vitro
###end title 42
###begin p 43
Proximal IgHmu c-myc/IgH chromosomal translocation.
###end p 43
###begin p 44
###xml 39 48 39 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003927-g002">figure 2b</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse identification as referred to in figure 2b.
###end p 44
###begin p 45
c-myc sequence adjacent to translocation junction. Mutations are shown in lowercase.
###end p 45
###begin p 46
Microhomology at junctions (overlapping sequences that cannot be assigned to a single sequence, c-myc, or Ig).
###end p 46
###begin p 47
IgH Reverse complementary sequence adjacent to translocation junction. Mutations are shown in lowercase.
###end p 47
###begin p 48
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
From this result we conclude that the reduced AID levels expressed by mice that harbour a single copy of the gene (AID+/-) results in a decreased frequency of c-myc/IgH translocations. Therefore, AID is haploinsufficient for the generation of these lymphomagenic lesions.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Muramatsu1">[6]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Muramatsu1">[6]</xref>
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Revy1">[7]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pasqualucci2">[27]</xref>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Liu1">[28]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro2">[20]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pasqualucci1">[22]</xref>
###xml 798 805 798 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Pasqualucci1">[22]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kovalchuk1">[23]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kotani1">[24]</xref>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Chesi1">[25]</xref>
The progress of the humoral immune response relies on the reshaping of the antibody repertoire upon infection by the introduction of somatic changes into the DNA of Ig genes. Higher affinity antibodies are produced by SHM and new effector capabilities are generated by CSR. SHM and CSR are initiated by AID through the deamination of cytosine residues on antibody genes [6]. Accordingly, AID is a critical enzymatic activity for the development of the adaptive immune response [6], [7]. Recent reports have stated that AID-mediated deamination on DNA can also lead to the generation of unwanted lesions, namely, mutations outside the Ig genes [27], [28], or DNA breaks and chromosomal translocations [19], [20], [21], [22], whose contribution to lymphoid neoplasia has been demonstrated in several in vivo models [19], [21], [22], [23], [24], [25]. Therefore AID function is expected to be tightly regulated to prevent the generation of DNA lesions.
###end p 50
###begin p 51
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Takizawa1">[36]</xref>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
Here, we have addressed the question of whether restriction of AID expression levels in vivo could play a regulatory role in its activity. We performed our analyses in mice that harbour a single functional allele of the AID gene, which results in a reduction of roughly 50% of AID mRNA levels. This reduction is likely due to a per-cell decrease of AID levels, as it has been shown that AID expression is biallelic [36].
###end p 51
###begin p 52
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 636 639 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 685 693 685 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Takizawa1">[36]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-McBride2">[39]</xref>
###xml 1118 1121 1118 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Revy1">[7]</xref>
###xml 1123 1127 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Kasahara1">[40]</xref>
###xml 1129 1133 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Quartier1">[41]</xref>
###xml 1135 1139 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Zhu1">[42]</xref>
###xml 1355 1358 1355 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Revy1">[7]</xref>
###xml 1360 1364 1360 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Quartier1">[41]</xref>
###xml 1366 1370 1366 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Imai1">[43]</xref>
###xml 1578 1581 1578 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Revy1">[7]</xref>
###xml 1583 1587 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Quartier1">[41]</xref>
###xml 1589 1593 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Imai1">[43]</xref>
###xml 1595 1599 1595 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ta1">[44]</xref>
###xml 1673 1677 1673 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Durandy1">[45]</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 17 23 <span type="species:ncbi:9606">humans</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 1042 1048 <span type="species:ncbi:9606">humans</span>
###xml 1221 1229 <span type="species:ncbi:9606">patients</span>
###xml 1489 1497 <span type="species:ncbi:9606">patients</span>
###xml 1634 1642 <span type="species:ncbi:9606">patients</span>
Both in mice and humans, the absence of AID results in a hyper IgM immunodeficiency syndrome that is characterized by the absence of somatic mutations and of Ig isotypes other than IgM. This phenotype is accompanied by lymphoid hyperplasia and enlarged germinal centers. Although the significance of these latter features to the immunodeficiency is unclear, we found that reduction of AID expression in AID+/- mice brings about a mild increase of B cell numbers in the spleen and of germinal center cells in Peyer's patches. More importantly, AID gene dose is indeed limiting for the generation of switched isotypes, as B cells from AID+/- mice have an impaired ability to perform CSR in vitro, in agreement with very recently published results [36], [39] This observation is reinforced by the finding that exogenous AID expression results in an increase of the CSR rate. In addition, our results show that AID expression is also limiting for SHM. Altogether these data indicate that AID is haploinsufficient for antibody diversification. In humans, AID deficiency (HIGM2) is considered an autosomal recessive disease [7], [40], [41], [42]. This apparent discrepancy with our data can be explained by the fact that HIGM2 patients have relatively mild and variable clinical phenotypes, possibly due to the contribution of genetic and environmental factors [7], [41], [43]. Among those, it is important to note that numerous different mutations in the AID gene have been identified in HIGM2 patients, whose impact on the efficiency of the CSR and SHM reactions is highly variable [7], [41], [43], [44]. In addition, the number of HIGM2 patients characterised so far is small [45], which makes it very difficult to establish genotype-phenotype relationships. Therefore, it is expected that heterozygous individuals display mild to absence of clinical manifestations.
###end p 52
###begin p 53
###xml 258 261 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 592 596 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Xue1">[46]</xref>
###xml 819 827 806 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 922 925 909 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1021 1025 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Takizawa1">[36]</xref>
###xml 1053 1060 1040 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1291 1294 1278 1281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1295 1299 <span type="species:ncbi:10090">mice</span>
Our analysis of AID-induced chromosomal translocations shows that elimination of one AID allele reduces the frequency of these aberrations. Of note, c-myc/IgH translocations involving the distal Salpha switch region were not detected in B cells from IL6tgAID+/- hyperplasic lymph nodes. Although the sample size does not allow concluding that this absence is absolute, our data indicate that Salpha translocations are very infrequent when the amount of AID is limiting. This observation is in agreement with the finding that the frequency of AID mutations in Salpha is much lower than in Smu [46]. In turn, this would imply that, in the presence of a single AID allele, the lesions that trigger a DSB in this region are very rare and fall below our detection limit. Analysis of AID-promoted c-myc/IgH translocations in in vitro stimulated B cells has allowed an accurate measurement of the frequency of these events in AID+/- B cells, as opposed to the IL6tg (this study) or pristane induced plasmacytomas in Bcl-xL mice [36], where the contribution of in vivo selective mechanisms can not be discriminated. Our results show unequivocally that reduction of AID levels results in a significant decrease in the frequency of these events. This reduction in c-myc/IgH translocations found in AID+/- mice is not accompanied by a shift in the location or nature of translocation breakpoints, which indicates that diminishing AID levels affects only the frequency of targeting, rather than its specificity.
###end p 53
###begin p 54
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro2">[20]</xref>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 749 752 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 762 764 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 853 856 853 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Dorsett1">[19]</xref>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Ramiro3">[21]</xref>
###xml 952 955 952 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1035 1039 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003927-Takizawa1">[36]</xref>
###xml 1145 1152 1145 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
Conversely, we had previously observed that AID overexpression in primary B cells produces a major increase in the frequency of c-myc/IgH translocations. In particular, a ten fold protein increase gave rise to a thousand fold increase in translocation frequency [20]. This observation suggests that surpassing a certain level of AID expression is likely to overwhelm the cellular surveillance pathways that protect against these lesions and to result in their accumulation in a non-linear fashion. Together, these results show that AID haploinsufficiency is also revealed in its deleterious activity as promoter of illegitimate chromosome fusions. Interestingly, previous results have shown a longer median survival for IL6tgAID+/- than for IL6tgAID+/+mice (7.9 vs 5.5 months) in two independent studies which showed similar survival curves for IL6tgAID-/- mice [19], [21]. Very recently it has been reported that in a Bcl-xL transgenic background, AID+/- mice have a delayed plasmacytoma development in response to pristane injection [36]. Together, these observations indicate that AID haploinsufficiency can be relevant for tumor progression in vivo.
###end p 54
###begin p 55
###xml 69 73 <span type="species:ncbi:10090">mice</span>
In summary, we have found that a half reduction of AID expression in mice harbouring a single AID allele, results in a reduction of AID activity, both in the efficiency of antibody diversification and in the frequency of generation of chromosome translocations. This implies that there is a gene dose effect of AID expression, and therefore, that AID is haploinsufficient. Our findings suggest that restraining the physiologic levels of AID expression can be a mechanism that allows the achievement of an optimal balance between immune proficiency and genome integrity.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, B cell cultures, flow cytometry and ELISA assays
###end title 57
###begin p 58
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BL/6</italic>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 282 285 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 311 314 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1710 1713 1687 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1718 1721 1695 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1729 1732 1706 1709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 832 838 <span type="species:ncbi:9913">bovine</span>
###xml 1494 1498 <span type="species:ncbi:10090">mice</span>
###xml 1733 1737 <span type="species:ncbi:10090">mice</span>
###xml 1762 1767 <span type="species:ncbi:10090">mouse</span>
Congenic Balb/c AID+/- mice were obtained by breeding Balb/c AID-/- mice (Ramiro et al., 2004) with wild type Balb/c mice. p53+/-AID+/- mice were obtained by breeding Balb/c AID-/- mice with C57BL/6J p53-/- mice (Jackson laboratories). Lymph node samples were obtained from IL6tgAID+/+, IL6tgAID+/- and IL6tgAID-/- mice (Ramiro et al., 2004, Dorsett 2007). All experiments with mice were performed following the Animal Bioethics and Comfort Committee protocols approved by the Instituto de Salud Carlos III. B cells were purified from spleens by anti-CD43 immunomagnetic depletion (Miltenyi Biotech), labelled with 5 microm CFSE (Molecular Probes) (when indicated) and cultured in RPMI in the presence of 25 microg/ml LPS (Sigma), 10 ng/ml IL-4 (Peprotech), 10 mM Hepes (Gibco), 50 microM beta-mercaptoethanol (Gibco) and 10% fetal bovine serum (Gibco). For class switch recombination and differentiation assays BAFF (20 ng/ml R&D Systems) was also included to the previously described medium. Retroviral transductions were performed in LPS+IL4 stimulated B cells in the presence of 8 microg/ml polybrene. Flow cytometry analysis was performed after staining with anti-GL7-FITC, anti-CD95-PE, anti-CD19-APC, anti-IgG1 biotin and anti-IgG3 antibodies, APC-streptavidin and 7-AAD (all from BD Biosciences) in a FACSCanto flow cytometer (BD Biosciences). P-values were calculated using unpaired Student's t test (GraphPad software). For determination of serum Ig titers, age-matched 7-9 weeks old mice were immunized by footpad injection with 50 microg/ml of NP-CGG (Biosearch Technologies) in complete Freund's adjuvant. Serum was collected from blood samples 15 days after the immunization and IgG titers in AID+/+, AID+/- and AID-/- mice were determined using a mouse IgG specific ELISA system (Roche Applied Science).
###end p 58
###begin title 59
Real time quantitative PCR
###end title 59
###begin p 60
###xml 386 413 386 413 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCTTCGCAACAAGTCTGGCT-3&#8242;</named-content>
###xml 417 444 417 444 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCCTTGCGGTCTTCACAGAA-3&#8242;</named-content>
###xml 470 495 470 495 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAAGCAGGCATCTGAGGG-3&#8242;</named-content>
###xml 499 525 499 525 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGAAGGTGGAAGAGTGGGAG-3&#8242;</named-content>
Total RNA was isolated with Trizol (Invitrogen) after Ficoll gradient centrifugation (Amerham Biosciences) of stimulated B cells and converted into cDNA using random primers (Roche) and SuperScript II Reverse transcriptase (Invitrogen). AID mRNA was quantified using SYBR Green assay (Applied Biosystems). GAPDH amplifications were used as normalization controls. Primers for AID were: 5'-ACCTTCGCAACAAGTCTGGCT-3'and 5'-AGCCTTGCGGTCTTCACAGAA-3'. Primers for GAPDH were: 5'-TGAAGCAGGCATCTGAGGG-3'and 5'-CGAAGGTGGAAGAGTGGGAG-3'. Quantitative PCRs were performed on 7900HT fast real-time PCR system (Applied Biosystems). P-values were calculated using paired Student's t test (GraphPad software).
###end p 60
###begin title 61
Mutation analysis
###end title 61
###begin p 62
###xml 49 50 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 288 329 287 328 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATGGATACCTCAGTGGTTTTTAATGGTGGGTTTA-3&#8242;</named-content>
###xml 334 369 333 368 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGGCCCGGCTCATTCCAGTTCATTACAG-3&#8242;</named-content>
###xml 439 440 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 444 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 570 595 569 594 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGGACTTTCGGTTTGGTG-3&#8242;</named-content>
###xml 618 643 617 642 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGTCAAGGAACCTCAGTCA-3&#8242;</named-content>
###xml 648 672 647 671 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTCTAGACAGCAACTAC-3&#8242;</named-content>
For analysis of mutations at the Smu region, CD43- spleen B cells were CFSE labelled, stimulated for 96h in the presence of LPS and IL4 and B cells that had undergone 5 or more cell divisions were isolated by sorting (FACSAria). DNA was extracted and amplified using the oligonucleotides 5'-AATGGATACCTCAGTGGTTTTTAATGGTGGGTTTA-3' and 5'-GCGGCCCGGCTCATTCCAGTTCATTACAG-3'y for 26 cycles (Pfu Ultra, Stratagene). For JH4 intron mutations, Fas+GL7+ cells were purified by cell sorting (FACSAria), DNA was isolated and amplified with oligonucleotides 5'ACTATGCTATGGAC-3' and 5'-CTGGACTTTCGGTTTGGTG-3' for 9 cycles and then 5'-GGTCAAGGAACCTCAGTCA-3' and 5'-TCTCTAGACAGCAACTAC-3' for 21 cycles using Pfu Ultra (Stratagene). Amplification products were purified, cloned and sequenced. Sequence analysis was performed using Lasergene software. P-values were calculated using unpaired Student's t test (GraphPad software).
###end p 62
###begin title 63
Translocations assays
###end title 63
###begin p 64
###xml 145 148 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 388 421 378 411 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAGGACCAGAGAGGGATAAAAGAGAA-3&#8242;</named-content>
###xml 426 457 416 447 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGGAGGGGGTGTCAAATAATAAGA-3&#8242;</named-content>
###xml 503 534 492 523 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCCTGCTATTTCCTTGTTGCTAC-3&#8242;</named-content>
###xml 539 572 528 561 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACACCTCCCTTCTACACTCTAAACCG-3&#8242;</named-content>
###xml 620 651 605 636 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTGAATCAGGCAGCCGATTATCAC-3&#8242;</named-content>
###xml 656 689 641 674 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGGGAGGGGGTGTCAAATAATAAGA -3&#8242;</named-content>
###xml 738 774 719 755 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGCTGACCAACAGTTCTGGCTGTATAGAC-3&#8242;</named-content>
###xml 779 813 760 794 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACACCTCCCTTCTACACTCTAAACCG -3&#8242;</named-content>
###xml 1080 1082 1057 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1125 1159 1102 1136 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGGTATACAGGACGAAACTGCAGCAG-3&#8242;</named-content>
###xml 1177 1209 1154 1186 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCAGCGATTCAGCACTGGGTGCAGG-3&#8242;</named-content>
C-myc/IgH translocation detection by PCR was performed as previously described (Ramiro et al., 2004; Kovalchuk et al., 1997) on 1 microg (for p53+/- samples) or 500-4 ng (for IL6tg samples) of genomic DNA. C-myc/IgHmu and c-myc/IgHalpha translocations were amplified using two rounds of PCR with Expand Long Template PCR system (Roche). Primers for derivative 12 c-myc/IgHmu first round: 5'-TGAGGACCAGAGAGGGATAAAAGAGAA-3' and 5'-GGGGAGGGGGTGTCAAATAATAAGA-3'; for derivative 12 c-myc/IgHmu second round: 5'-CACCCTGCTATTTCCTTGTTGCTAC-3' and 5'-GACACCTCCCTTCTACACTCTAAACCG-3'; for derivative 12 c-myc/IgHalpha first round: 5'-CGTGAATCAGGCAGCCGATTATCAC-3' and 5'- GGGGAGGGGGTGTCAAATAATAAGA -3'; for derivative 12 c-myc/IgHalpha second round: 5'-GAGCTGACCAACAGTTCTGGCTGTATAGAC-3' and 5'-GACACCTCCCTTCTACACTCTAAACCG -3'. PCR products were purified, cloned and sequenced. Translocation sequences were aligned using SeqMan from Lasergene software. PCR products were separated on agarose gels and denatured for 20 min in 0.4M NaOH before transfer to nylon membranes and probed with gamma-P32-ATP labelled oligonucleotides (IgH probe: 5'-CCTGGTATACAGGACGAAACTGCAGCAG-3' and c-myc probe: 5'- GCAGCGATTCAGCACTGGGTGCAGG-3'). P-values were calculated using two-tail Fisher's test (GraphPad software).
###end p 64
###begin p 65
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
We would like to thank Dr T Honjo and Dr T Kishimoto, who generated the original AID deficient mice and IL6 transgenic mice, respectively.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
V(D)J recombination.
###end article-title 67
###begin article-title 68
The biochemistry of somatic hypermutation.
###end article-title 68
###begin article-title 69
Molecular mechanisms of antibody somatic hypermutation.
###end article-title 69
###begin article-title 70
Antibody class switching.
###end article-title 70
###begin article-title 71
Molecular processes that regulate class switching.
###end article-title 71
###begin article-title 72
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.
###end article-title 72
###begin article-title 73
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).
###end article-title 73
###begin article-title 74
Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase.
###end article-title 74
###begin article-title 75
Transcription-targeted DNA deamination by the AID antibody diversification enzyme.
###end article-title 75
###begin article-title 76
AID mediates hypermutation by deaminating single stranded DNA.
###end article-title 76
###begin article-title 77
In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).
###end article-title 77
###begin article-title 78
Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation.
###end article-title 78
###begin article-title 79
Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand.
###end article-title 79
###begin article-title 80
Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase.
###end article-title 80
###begin article-title 81
Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation.
###end article-title 81
###begin article-title 82
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice.
###end article-title 82
###begin article-title 83
Mechanisms of B-cell lymphoma pathogenesis.
###end article-title 83
###begin article-title 84
Mechanisms of chromosomal translocations in B cell lymphomas.
###end article-title 84
###begin article-title 85
A role for AID in chromosome translocations between c-myc and the IgH variable region.
###end article-title 85
###begin article-title 86
Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.
###end article-title 86
###begin article-title 87
AID is required for c-myc/IgH chromosome translocations in vivo.
###end article-title 87
###begin article-title 88
AID is required for germinal center-derived lymphomagenesis.
###end article-title 88
###begin article-title 89
###xml 21 36 <span type="species:ncbi:10090">transgenic mice</span>
AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.
###end article-title 89
###begin article-title 90
###xml 79 82 <span type="species:ncbi:8790">Emu</span>
###xml 88 103 <span type="species:ncbi:10090">transgenic mice</span>
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.
###end article-title 90
###begin article-title 91
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.
###end article-title 91
###begin article-title 92
Targeting of somatic hypermutation.
###end article-title 92
###begin article-title 93
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
###end article-title 93
###begin article-title 94
Two levels of protection for the B cell genome during somatic hypermutation.
###end article-title 94
###begin article-title 95
Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1.
###end article-title 95
###begin article-title 96
Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase.
###end article-title 96
###begin article-title 97
Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells.
###end article-title 97
###begin article-title 98
Activation-induced deaminase: light and dark sides.
###end article-title 98
###begin article-title 99
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation.
###end article-title 99
###begin article-title 100
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.
###end article-title 100
###begin article-title 101
miR-181b negatively regulates activation-induced cytidine deaminase in B cells.
###end article-title 101
###begin article-title 102
AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.
###end article-title 102
###begin article-title 103
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
IL-6 transgenic mouse model for extraosseous plasmacytoma.
###end article-title 103
###begin article-title 104
Deletional remodeling of c-myc-deregulating chromosomal translocations.
###end article-title 104
###begin article-title 105
Regulation of class switch recombination and somatic mutation by AID phosphorylation.
###end article-title 105
###begin article-title 106
Hyper-IgM syndrome with putative dominant negative mutation in activation-induced cytidine deaminase.
###end article-title 106
###begin article-title 107
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.
###end article-title 107
###begin article-title 108
Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase.
###end article-title 108
###begin article-title 109
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
###end article-title 109
###begin article-title 110
AID mutant analyses indicate requirement for class-switch-specific cofactors.
###end article-title 110
###begin article-title 111
Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
###end article-title 111
###begin article-title 112
###xml 118 122 <span type="species:ncbi:10090">mice</span>
The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: IVS is funded by Comunidad Autonoma de Madrid, VGY is a CNIO investigator and ARR is supported by the Ramon y Cajal programe from the Ministerio de Educacion y Ciencia. This work has been funded by grants from Ministerio de Educacion y Ciencia (SAF2007-63130), Comunidad Autonoma de Madrid (DIFHEMAT-CM) and European Research Council (BCLYM-207844). They have not had any role in the design, implementation, analysis, etc of the analysis.
###end p 114

